Sylvain M.
- Country
- France
- Department
- Hepato-gastroenterology
Research Overview
- Evaluation of Molecular Targeted Maintenance Therapy with Binimetinib, Futibatinib, and Drug Combination in Advanced Biliary Cancer: A Phase 3 Randomized Trial
- Phase II Randomized Trial of Modified FOLFIRINOX and FOLFOX Regimens in Locally Advanced or Metastatic Small Bowel Adenocarcinoma
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Durvalumab with Gemcitabine and Cisplatin in First-Line Advanced Biliary Tract Cancer
Data & Insights
Has run more than one trial at 123 of 221 partner sites.
Specializations
Hepatobiliary Oncology
The investigator specializes in treating hepatocellular carcinoma (HCC) through various therapeutic approaches, including innovative combinations of ablation procedures and targeted therapies. Their work encompasses both early-stage and advanced disease management.
- Curative Ablation Procedures
- Immunotherapy Combinations
- Targeted Molecular Therapies
A particular focus lies in developing treatment strategies for both resectable and non-resectable HCC cases.
Biliary Tract Cancers
The investigator has extensive involvement in treating advanced biliary tract cancers, exploring novel therapeutic approaches including personalized medicine strategies and immunotherapy combinations.
- First-line Treatment Optimization
- Immunotherapy Integration
- Adjuvant Therapy Development
Their work includes evaluating innovative treatment combinations for both advanced and resected biliary tract carcinomas.
Gastrointestinal Oncology
The investigator conducts research in various gastrointestinal cancers, including rectal cancer, small bowel adenocarcinoma, and esophageal squamous cell carcinoma.
- Neoadjuvant Treatment Strategies
- Chemotherapy Optimization
- Elderly Patient Care
Their research includes developing treatment approaches for both early-stage and advanced gastrointestinal malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.